Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.

Details

Language :

English

ISSN :

01406736

Volume :

369

Issue :

9568

Database :

Academic Search Index

Journal :

Lancet

Publication Type :

Academic Journal

Accession number :

105614064

Full Text :

https://doi.org/10.1016/s0140-6736(07)60497-8